Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Biological Psychology
|
March 4, 2000
Cardiovascular and secretory immunoglobulin A reactions to humorous, exciting, and didactic film presentations
L K Harrison, D Carroll, V E Burns, et al.
Leukemia
|
October 26, 2002
An unrelated cytogenetic karyotype and intra-lineage shift at relapse of an aggressive paediatric B-precursor ALL
V J Weston, T Stankovic, D J McMullan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 1988
The behavior of autologous indium-114m-labeled lymphocytes in patients with lymphoid cell malignancy
D Hamilton, R A Cowan, H L Sharma, et al.
Nuclear Medicine Communications
|
October 1, 1988
114Inm oxine-labelled lymphocytes--therapeutic applications
D Hamilton, R A Cowan, M Drayson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2000
High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment
F E Davies, S J Rollinson, A C Rawstron, et al.
The Biochemical Journal
|
April 4, 2001
Up-regulation of steroid sulphatase activity in HL60 promyelocytic cells by retinoids and 1alpha,25-dihydroxyvitamin D3
P J Hughes, L E Twist, J Durham, et al.
Leukemia
|
July 24, 2015
Metabolic plasticity in CLL: adaptation to the hypoxic niche
K M Koczula, C Ludwig, R Hayden, et al.
British Journal of Cancer
|
February 27, 2014
Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate
F Khanim, N Davies, P Veliça, et al.
British Journal of Haematology
|
March 22, 2001
The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma
F E Davies, P D Forsyth, A C Rawstron, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Biological Psychology
|
March 4, 2000
Cardiovascular and secretory immunoglobulin A reactions to humorous, exciting, and didactic film presentations
L K Harrison, D Carroll, V E Burns, et al.
Leukemia
|
October 26, 2002
An unrelated cytogenetic karyotype and intra-lineage shift at relapse of an aggressive paediatric B-precursor ALL
V J Weston, T Stankovic, D J McMullan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 1988
The behavior of autologous indium-114m-labeled lymphocytes in patients with lymphoid cell malignancy
D Hamilton, R A Cowan, H L Sharma, et al.
Nuclear Medicine Communications
|
October 1, 1988
114Inm oxine-labelled lymphocytes--therapeutic applications
D Hamilton, R A Cowan, M Drayson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2000
High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment
F E Davies, S J Rollinson, A C Rawstron, et al.
The Biochemical Journal
|
April 4, 2001
Up-regulation of steroid sulphatase activity in HL60 promyelocytic cells by retinoids and 1alpha,25-dihydroxyvitamin D3
P J Hughes, L E Twist, J Durham, et al.
Leukemia
|
July 24, 2015
Metabolic plasticity in CLL: adaptation to the hypoxic niche
K M Koczula, C Ludwig, R Hayden, et al.
British Journal of Cancer
|
February 27, 2014
Selective AKR1C3 inhibitors do not recapitulate the anti-leukaemic activities of the pan-AKR1C inhibitor medroxyprogesterone acetate
F Khanim, N Davies, P Veliça, et al.
British Journal of Haematology
|
March 22, 2001
The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma
F E Davies, P D Forsyth, A C Rawstron, et al.
Page
of 3